Can a company of one make a difference in today’s life science industry? In a recent article by Ron Leuty of BioTechSF apparently so. Hari Kumar the company’s sole employee recently closed a deal with Roche for 105M upfront payment and 475M based on milestones. This is based on technology that could lead to new treatments for rheumatoid arthritis and fibrotic diseases.
While Hari is the company’s sole employee his workforce is composed of a team of 9-contractors. Initially skeptical of the virtual company model, Kumar is an advocate of the virtual model.